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Abstract
 
Natural resistance to infection with mouse cytomegalovirus (MCMV) is controlled by a domi-
nant locus, 
 
Cmv1
 
. 
 
Cmv1
 
 is linked to the 
 
Ly49
 
 family of natural killer receptors on distal chro-
mosome 6. While some studies localized 
 
Cmv1
 
 as distal to the 
 
Ly49
 
 gene cluster, genetic and
functional analysis identified 
 
Ly49h
 
 as a pivotal factor in resistance to MCMV. The role of
these two independent genomic domains in MCMV resistance was evaluated by functional
complementation using transgenesis of bacterial artificial chromosomes (BAC) in genetically
susceptible mice. Phenotypic and genetic characterization of the transgenic animals traced the
resistance gene to a single region spanning the 
 
Ly49h
 
 gene. The appearance of the Ly49H pro-
tein in NK cells of transgenic mice coincided with the emergence of MCMV resistance, and
there was a threshold Ly49H protein level associated with full recovery. Finally, transgenic ex-
pression of Ly49H in the context of either of the two independent susceptibility alleles,
 
Cmv1
 
sBALB
 
 or 
 
Cmv1
 
sFVB
 
, conferred resistance to MCMV infection. These results demonstrate
that 
 
Ly49h
 
 is necessary and sufficient to confer MCMV resistance, and formally demonstrate
allelism between 
 
Cmv1
 
 and 
 
Ly49h
 
. This panel of transgenic animals provides a unique resource
to study possible pleiotropic effect of 
 
Cmv1
 
.
Key words: genetic complementation test • natural immunity • animal model • 
immunogenetics • natural killer cells
 
Introduction
 
Experimental models of infection of mice with mouse cy-
tomegalovirus (MCMV)
 
*
 
 have provided an excellent tool
for the in vivo dissection of the individual components of
the host response responsible for mediating MCMV resis-
tance. Indeed, resistance/susceptibility to MCMV is under
multigenic control, with contributions from both 
 
H2
 
 and
 
non-H2
 
 genes exerting their effects at different levels. The
 
H2
 
 complex influences susceptibility to the lethal effect of
MCMV and viral titers in target organs (1, 2). However,
 
non-H2
 
 linked genes are also important in determining the
outcome of MCMV infection during the initial phase of
the infection. For example, in inbred mice, infection with a
sublethal dose of MCMV presents an early nonimmune
phase (0–6 d) characterized by either rapid proliferation of
the virus or reduced viral titers in target organs (3). This
early phase is controlled by a single dominant locus named
 
Cmv1
 
 (4). 
 
Cmv1
 
 presents two allelic forms in mouse strains,
either the dominant 
 
Cmv1
 
r
 
 (low virus titer, resistant) or the
recessive 
 
Cmv1
 
s
 
 (high virus titer, susceptible), with 
 
Cmv1
 
r
 
mouse strains being fivefold more resistant to lethal
MCMV infection, and exhibiting 3–4 log
 
10
 
 lower level of
viral replication in the spleen than 
 
Cmv1
 
s
 
 strains (4). The
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8M5, Canada. Phone: 613-562-5800 (8592); Fax: 613-562-5452; E-mail:
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*
 
Abbreviations used in this paper:
 
 BAC, bacterial artificial chromosome;
GST, glutathione S transferase; MCMV, mouse CMV; NKC, NK cell
gene complex; PAMP, pathogen associated molecular pattern; STS, se-
quence tagged site; TCF-1, T cell factor 1.T
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Mice Transgenic for Ly49H Are Resistant to MCMV
 
Cmv1
 
 locus is related to NK cells, a set of lymphocytes in-
volved in natural killing of tumor or virally infected cells.
Indeed, when NK cells are depleted with an anti-NK1.1
mAb, resistant C57BL/6 (
 
Cmv1
 
r
 
) mice become susceptible
(5). In addition, genetic mapping data indicated that 
 
Cmv1
 
maps to the mouse chromosome 6 and is tightly linked to
the NK cell gene complex (NKC; references 4, 6, and 7).
The NKC clusters numerous genes and gene families cod-
ing for highly related receptors of the C-lectin-type family
important for signaling activation or inhibition of NK cell
function (8).
Because of the genetic complexity of the NKC and the
absence of a reliable in vitro assay to assess susceptibility/re-
sistance to MCMV, at least two groups initiated a posi-
tional cloning approach to isolate 
 
Cmv1
 
 (7, 9–12). This
approach is based strictly on the knowledge of the
chromosomal location of a specific gene to achieve its mo-
lecular cloning, after chromosome walking toward the
gene from the most closely linked genetic markers on that
chromosome (13). Through meiotic and physical mapping
using classical inbred strains of mice, a minimal 
 
Cmv1
 
 in-
terval of 0.35 cM was defined (7, 10). This interval trans-
lated into 1.6 Mb of genomic DNA and contained a mini-
mum of 20 transcription units (11). Among them, members
of the 
 
Ly49
 
 (
 
Klra
 
) gene family of NK cell receptors ap-
peared to be the most attractive candidate genes for 
 
Cmv1
 
.
However, an independent mapping effort positioned 
 
Cmv1
 
within a 390-kb region distal to the 
 
Ly49b
 
 (9), which ex-
cludes all the members of 
 
Ly49
 
 gene family as a candidate
for 
 
Cmv1
 
. The combination of this interval with a 1.6-Mb
genetic interval generated by our group produced a 200-kb
overlapping region, suggesting the possibility of modifier
genes of MCMV-resistance in the BALB/c or A/J strains
used for mapping.
The genetic complexity of this genomic domain was
further underscored by haplotype analysis for a set of 25
markers in the vicinity of 
 
Cmv1
 
, which revealed the pres-
ence of different haplotypes in a panel of 18 inbred strains
of mice (14). Interestingly, the majority of strains analyzed
(16/18) were MCMV susceptible. Accordingly, the MCMV
resistance allele, 
 
Cmv1
 
r
 
, was associated with a haplotype
unique to strains of the C57BL background. Susceptible
strains could be classified in two groups based on their
haplotype at 
 
Cmv1
 
, indicating the presence of two unre-
lated MCMV susceptibility alleles, named 
 
Cmv1
 
sBALB
 
 and
 
Cmv1
 
sFVB
 
, raising the possibility of genetic heterogeneity at
 
Cmv1
 
, such as mutations in alternate 
 
Ly49
 
 members in dif-
ferent inbred strains. While the 
 
Cmv1
 
sBALB
 
 haplotype is dis-
tinct from 
 
Cmv1
 
r
 
 at every locus, identical alleles are shared
at several loci between 
 
Cmv1
 
sFVB
 
 and 
 
Cmv1
 
r
 
, indicating
that they share a common ancestral haplotype. Close in-
spection of these haplotypes pointed to two regions in
disequilibrium with susceptibility corresponding to the
 
Ly49d
 
-
 
Ly49a
 
 interval and to the genomic region distal to
 
Ly49b
 
 (14). A possible interpretation of this result is that
tightly linked loci at 
 
Cmv1
 
 contribute to MCMV suscepti-
bility or resistance.
 
Recently, three independent groups reported the 
 
Ly49h
 
gene as an important determinant in MCMV resistance
(15–17). We took advantage of the recombinant inbred
strain BXD-8, derived from 
 
Cmv1
 
r
 
 C57BL/6 and 
 
Cmv1
 
s
 
DBA/2 parents (18). This strain is of particular interest, as it
is highly susceptible to MCMV infection but harbors a
C57BL/6 haplotype at 
 
Cmv1
 
 (4). Using a combination of
linkage analyses in an informative (BXD-8 
 
 
 
 C57BL/6)F
 
2
 
population, together with genetic complementation in
vivo using mouse strains congenic for different 
 
Cmv1
 
 seg-
ments, physical mapping and expression analysis, we dem-
onstrated that the MCMV susceptibility trait of BXD-8 is
associated with a 23-kb deletion encompassing 
 
Ly49h
 
 (15).
At the same time, using a panel of monoclonal antibodies,
the laboratory of Yokoyama demonstrated that the Ly49H
receptor was absent from BXD-8 mice and, moreover, that
treatment with the anti-Ly49H monoclonal antibody 3D10
before MCMV infection abrogated MCMV-resistance in
the C57BL/6 mice (16). Welsh and coworkers confirmed
and extended these results by demonstrating that depletion
of Ly49H
 
 
 
 NK cells specifically affects MCMV response
but not that to vaccinia virus or lymphocytic choriomenin-
gitis virus (17). The Ly49H protein is an activating receptor
expressed in approximately half of the NK cell population
in adult C57BL/6 mice (19). Ly49H signals through the ki-
nase-associated adaptor molecule DAP12 (20) probably
upon recognition of the MCMV-encoded molecule m157
(21, 22), a glycoinositol phospholipids
 
 (
 
GPI)-linked protein
structurally related to nonclassical MHC.
While several lines of experiments clearly demonstrate
that absence of Ly49H is associated with MCMV suscepti-
bility, it was important to evaluate the role of the distal
200-kb region during the MCMV response as well as to
determine whether expression of Ly49H is sufficient to
confer MCMV resistance in order to provide the formal
demonstration of 
 
Ly49h/Cmv1
 
 identity. To achieve this
aim we have used an approach of functional in vivo com-
plementation by genetic transfer of bacterial artificial chro-
mosome (BAC) clones overlapping important regions on
the 
 
Cmv1
 
 interval that we report here. The results obtained
from this study clearly pinpointed the precise location of
 
Cmv1
 
, providing conclusive evidence that 
 
Cmv1
 
 and 
 
Ly49h
 
are allelic. In addition, these transgenic mice provided an
opportunity to investigate several questions regarding the
role of Ly49H during MCMV infection such as the thresh-
old of Ly49H
 
 
 
 NK cells for 
 
Cmv1
 
, the possible genetic het-
erogeneity of 
 
Cmv1
 
, and the rescue by the transfer of 
 
Ly49h
 
on different 
 
Cmv1
 
 susceptible backgrounds.
 
Materials and Methods
 
Mice.
 
All mice were initially purchased from The Jackson
Laboratory and subsequently maintained at the animal facility at
the University of Ottawa in agreement with guidelines and regu-
lations of the Canadian Council of Animal Care.
 
Generation of BAC Transgenic Mice.
 
BAC clones 13J11 and
128D23 spanning the corresponding candidate regions within
our 
 
Cmv1
 
 interval were previously described (11). These BACT
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clones were obtained from RPCI-23 mouse BAC library origi-
nated from DNA of C57BL/6 (
 
Cmv1
 
r
 
 MCMV-resistant) strain
(Research Genetics). The BAC DNA was isolated by the alka-
line lysis method with gentle handling to prevent the breakage
of BAC DNA, linearized by either NotI or XhoI/SalI digestion,
and size fractionated on 1% low melting agarose gel using pulsed
field gel electrophoresis (PFGE; 6 V/cm, 120 angle, 6 s of
switching time for 24 h). The BAC insert DNA was recovered
from the gel by 
 
 
 
-Agarase I treatment (New England Bi-
oLabs, Inc.) without exposure to UV light, as described (23),
and purified by dialysis for 4 h against microinjection buffer (10
mM Tris, pH 7.5, 0.1 mM EDTA) by floating on a Millipore
VSWP 2500 (pore 0.05 
 
 
 
m) filter disc. The BAC DNA was
microinjected into fertilized pronucleus of fertilized eggs de-
rived from FVB/N at 1.5 ng/
 
 
 
l concentration. After injection,
the eggs were transferred into the oviduct of 0.5-d pseudo-
pregnant foster CD-1 female mice. All procedures for generat-
ing BAC transgenic mice were performed at the transgenic
facility of the Ottawa Hospital Research Institute or McGill
University. Transgenic founders were identified via PCR (see
below) and subsequently bred to BXD-8, FVB/N, and BALB/c
mice by serial backcrossing.
 
Genomic DNA Analysis.
 
To identify the presence of BAC
DNA, tail DNA was extracted using alkaline lysis. Briefly, a
2-mm tail biopsy was incubated in 600 
 
 
 
l of a 50 mM NaOH so-
lution at 95
 
 
 
C for 20 min with mixing every 5 min. At the end of
the incubation, the DNA solution was vortexed for 30 s and neu-
tralized by adding 50 
 
 
 
l of 1 M Tris (pH 7.0). Aliquots of 2 
 
 
 
l of
this solution were used for PCR reactions. A first round of PCR
screening was done using the following set of primers:
5
 
 
 
-GCCGCTAATACGACTCACTATAGGG-3  and 5 -GAA-
GATTTGCAGGCCAGGAG-3  (amplified a 163-bp fragment
from the T7-end of BAC 13J11 vector-insert junction) and
5 -CCGTCGACATTTAGGTGACAC-3  and 5 -CTGAGT-
TCAATTCCTAATTC-3  (amplified a 187-bp fragment from
the SP6-end of BAC 13J11 vector-insert junction); 5 -GC-
CGCTAATACGACTCACTATAGGG-3  and 5 -TCCTGCA-
GAAATCAGAGTTCTGTT-3  (amplified a 74-bp fragment
from the T7-end of BAC 128D23 vector-insert junction) and
5 -CCGTCGACATTTAGGTGACAC-3  and 5 -GGGGACT-
GAAAGATAGAAGTG-3  (amplified a 222-bp fragment from
the SP6-end of BAC 128D23 vector-insert junction). To confirm
the integrity of BAC DNA in the transgenic mice, several inter-
nal polymorphic markers were tested by PCR with previously re-
ported primer pairs (14, 15). In addition, Ly49e and D6Ott115
primer pairs (10) were used to determine the Cmv1 phenotype of
mice bred into the BALB/c background. To determine the copy
number of transgene on founder animal, 20 ng of tail DNA was
semiquantitatively analyzed by PCR at three different cycles and
their intensity compared with corresponding sample from ho-
mozygous C57BL/6 mice. Oligos specific for Ly49h intron1
were used to amplify B6 copies and the sequence of the oligos
were,  D6Ott151-F: 5 -GTGCTACCACTGAAAACCA-
TTG-3  and D6Ott151-R: 5 -CTGTCTCTTGAGTCACCT-
GCAC-3 .
Detection of Transgene Expression by PCR Analysis. Transgene
expression was detected by semiquantitative RT-PCR. Briefly,
total splenic RNA was extracted using Trizol reagent (Life Tech-
nologies), and 2  g of total RNA was reverse transcribed using
oligo-dT primers and Superscript II reverse transcriptase accord-
ing to the manufacturer’s protocols (Life Technologies). Gene
specific oligonucleotides for the PCR step were, EST335500-F:
5 -GGCCGTGGTCGCAGTGAACT-3  and EST335500-R:
5 -GCTGGCTTCTCTGGCCACCT-3 ; Ly49d-F: 5 -GGCT-
CAAGGAGACACGGAAG-3  and Ly49d-R: 5 -TCCCAAA-
ATCTTCCAGATTG-3 ;  Ly49h-F: 5 -AGCCTCTTAGGG-
GATACAGAC-3  and Ly49h-R: 5 -TGTCAAGATAGAT-
AGGAGAGG-3 ;  Ly49i-F: 5 -GATGAATGAGCCGGAG-
GTC-3  and Ly49i-R: 5 -TTTCACTGTTCCATCTGTCCT-
3 ;  Gapdh-F: 5 -ACCACAGTCCATGCCATCAC-3  and
Gapdh-R: 5 -TCCACCACCCTGTTGCTGTA-3 .
Production of Anti-Ly49H Antibodies. Antibodies against
Ly49H were generated in rabbits using a bacterial glutathione S
transferase (GST)-fusion protein encompassing amino acids resi-
dues 1 to 44 which corresponds to the entire cytoplasmic domain
of Ly49H. The anti-Ly49H serum was adsorbed on GST-sepha-
rose 4B beads and anti-Ly49H antibodies were immunoaffinity
purified on GST/Ly49H fusion protein coupled to sepharose
beads as described (24).
Flow Cytometric Analysis. To isolate splenic leukocytes,
spleen was ground between rough surfaces of glass slides and
treated with Red Blood Cell Lysing Buffer (Sigma-Aldrich) to
remove red blood cells. For isolation of leukocytes from liver, the
organ was homogenized with a tissue grinder and the homoge-
nate was passed through a fine metal screens to remove large de-
bris and cell clumps. Then, 25% of hepatic cells were layered
over Lympholyte-M (Cedarlane) and centrifuged for 20 min at
1,500 g at room temperature to remove red blood cells. After
centrifugation, a lymphocyte layer at the interface was collected
using Pasteur pipette. NK cells were enriched from spleen and
liver leukocytes by magnetic positive separation using anti-DX5
microbeads following the manufacturer’s protocol (MACS®;
Miltenyi Biotec). The freshly purified DX5  NK cells were
stained for surface expression of DX5 using PE-conjugated mu-
rine anti-DX5 (BD Biosciences). After washing, the cells were
fixed, permeabilized and internally stained for cytoplasmic tails of
Ly49H receptor. FITC-conjugated anti–rabbit IgG (BD Bio-
sciences) was used to stain polyclonal anti-Ly49H that was previ-
ously bound. Cell population was analyzed by flow cytometry on
an Epics analyzer (Coulter).
Cmv1 Phenotype. Mice between 6 and 8 wk of age were
challenged with a virulent stock of the MCMV Smith strain (7)
originally obtained from the American Type Culture Collec-
tion. Mice were injected intraperitoneally with 0.2 ml of PBS
containing 5   103 PFU of MCMV. At 3 d after infection, the
degree of viral replication in the spleen and the liver was deter-
mined by plaque assay in mouse embryonic fibroblasts as de-
scribed (7).
Statistical Analysis. Significance of the differences observed
for viral titers or the size of Ly49H  NK cell population in refer-
ence to control nontransgenic groups or between transgenic lines
was assessed using the two-tailed Student’s t test.
Results
Characterization of BAC Clones Used in Transgenesis. In
the absence of an in vitro system for Cmv1, we used in vivo
complementation with BAC clones expressed in transgenic
mice as a functional assay for the Cmv1 gene. We reasoned
that introduction of the dominant Cmv1r (C57BL/6) allele
onto a recessive Cmv1s background should produce F1
progeny uniformly resistant to MCMV infection. High res-
olution genetic and physical mapping of the Cmv1 interval
identified a minimal genetic interval that is flanked by the
markers D6Ott8 and D6Ott115 and which corresponds toT
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a physical distance of  1.6 Mb of genomic DNA (Fig. 1, A
and B; references 10 and 11). Within this large interval,
two regions were of particular interest for complementa-
tion analysis: a distal candidate region of  200 kb that cor-
responds to the common domain for Cmv1 as defined from
two independent mapping efforts (9, 10), and a proximal
candidate region of  23 kb encompassing Ly49h whose
absence is associated with susceptibility to cytomegalovirus
in BXD-8 mice (Fig. C; references 15 and 16).
In the process of cloning Cmv1, we have previously
completed a physical map in the Cmv1 interval using a se-
ries of 73 overlapping BAC clones and screened the BAC
clones to provide genomic segments fully encompassing
each candidate region (11). Based on these considerations,
BAC clones 13J11 and 128D23 were identified for com-
plementation analysis (Fig. 1 C). The BAC 13J11 spans the
common Cmv1 interval (200 kb) as shown by the presence
of marker 200H7L, a YAC end defining the proximal
boundary of Cmv1 in Brown et al.’s map (9), as well as
D6Ott115, a marker defining the distal end of the Cmv1
interval in Depatie et al.’s map (10). Genomic DNA se-
quence analysis indicated the presence of at least three dif-
ferent transcription units in BAC 13J11, including a
pseudogene for one of the chromatine proteins of the High
Mobility Group (25) and the gene for the taste receptor
T2R (26) localized distal to D6Ott115. The third gene,
which presents 5 copies, corresponds to EST335500 (Gen-
Bank/EMBL/DDBJ accession no. W18806), a novel
spleen-specific gene whose expression is absent in the sus-
ceptible BALB/c strain (see below). The BAC clone
128D23 is located in the middle of Ly49 gene cluster
where it overlaps the 23-kb deletion present in the BXD-8
strain. This BAC clone contains five Ly49 genes, three
functional genes (Ly49d, Ly49h, and Ly49i) and two
pseudogenes (Ly49k and Ly49n) as deduced from its avail-
able genomic DNA sequence (GenBank/EMBL/DDBJ ac-
cession no. AC090127).
Production and Analysis of BAC Transgenic Mouse Lines for
Clone 13J11. We generated transgenic mice by injection
of purified BAC insert DNA into the male pronucleus of
FVB/N zygotes. Transgenic mice were identified by PCR
amplification of the BAC vector-insert junctions ends and
by the presence of internal polymorphic markers as indi-
cated in Fig. 2 A. In summary, 3 out of 20 founder animals
were positive for the transgenic markers and carried an in-
tact 210 kb transgenic construct (Fig. 2 A). The F1 progeny
of founder animals with BALB/c were analyzed by the
PCR approach, indicating transmission of the transgene to
 50% of their progeny as expected for nonmosaic germ-
line transmission.
To demonstrate proper expression of genes encoded in
BAC 13J11, we took advantage of the fact that only the
C57BL/6 allele of EST335500 is expressed in the mouse
spleen. As shown in Fig. 2 B, high levels of EST335500
RT-PCR product were obtained in spleen of the three
transgenic lines as well as from C57BL/6 RNA. No prod-
uct was observed in BALB/c samples. A control RT-PCR
with Gapdh primers demonstrates similar results for all sam-
ples, indicating that the RNA used as starting material was
consistent in quality and quantity in all the animals and that
genes in the construct were expressed in transgenic animals
(Fig. 2 B).
To examine the effect of BAC 13J11 in resistance
to MCMV, transgenic founders were backcrossed with
BALB/c, a susceptible strain used for mapping of Cmv1 (9,
10). After the acquisition of the context of homozygous
Cmv1sBALB haplotype in the Cmv1 interval, transgenic and
nontransgenic siblings were infected with MCMV and viral
titers in the spleen were measured 3 d after infection. As
shown in Fig. 2 C, no protective effect was observed in
Figure 1. Genomic targets for
transgenic analysis of the Cmv1
locus. (A) Composite genetic
linkage map of mouse chromo-
some 6 in the vicinity of Cmv1.
The order and distances of the
loci was determined by pedigree
analysis. The centromere is repre-
sented by a black circle. Recom-
bination frequencies in centimor-
gan (cM) are shown below the
chromosome.  Nk1.1,  Cd69,
Cd94, and Nkg2d code for C-lec-
tin type receptors. Prp, prolin-rich
protein;  Tel, translocation-ets-
leukemia (reference 7). (B) Blow-
up of the minimal genetic interval
between D6Ott8 and D6Ott115
and transcriptional map showing
candidate genes for Cmv1. Ar-
rows indicate the minimal Cmv1
interval as defined by Depatie et
al. (references 10 and 11) and
Brown et al. (reference 9) (C).
Localization of BAC clones used
for transgenesis (reference 11).T
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transgenic mice, which presented a viral load identical to
BALB/c (Cmv1s) and 102–103 times higher than the resis-
tant C57BL/6 mice. Taken together, these results indicate
that neither EST335500 nor any other genes in the 210-kb
region covered by 13J11 confer resistance to cytomegalo-
virus infection, excluding the presence of MCMV-resis-
tance genes within this genomic domain.
Production and Analysis of BAC Transgenic Mouse Lines for
Clone 128D23. The BAC 128D23 transgenic mice were
produced by microinjection of FVB/N (Cmv1s) zygotes,
and founder animals were analyzed by PCR with several
markers as shown in Fig. 3 A to identify transgenic mice. A
summary of the BAC transgenic lines and their characteris-
tics is presented in Table I. Out of 40 progenies, six
founders were shown to present an intact 128D23 insert,
while two of them missed one of two BAC ends (Fig. 3 A).
Interestingly, founder 043 showed discontinuous sequence
tagged site (STS) content, indicating possible rearrangement
between  Ly49f and Ly49n. Transgene copy number in
founder animals was determined using semiquantitative
PCR with Ly49h-specific primers. The range of transgene
copy numbers was 1 copy in line Tg915, 2 copies in line
Tg831 and 3–4 copies in line Tg832 (Fig. 3 B). Interest-
ingly, copy number correlated well with expression of
functional genes present in BAC 128D23 as shown by RT-
PCR analysis using Ly49d,  Ly49h, and Ly49i specific
primer pairs (Fig. 3 C). To note, primer pairs were also al-
lele specific for B6 transcripts since no product was de-
tected from nontransgenic FVB/N control RNA.
To monitor expression of Ly49H in different mouse
strains, we produced a polyclonal antibody against the cy-
toplasmic tail of the receptor. This antisera stained 52% of
DX5  NK cells isolated from C57BL/6 mouse spleen con-
sistent with previous results using an antibody directed
against the extracellular domain of Ly49H (19; Fig. 4 A).
No signal was observed in either FVB/N, BALB/c, or
BXD-8 indicating that this anti-Ly49H polyclonal anti-
body does not cross-react with other members of the Ly49
family. In particular, we have shown that, with the excep-
tion of Ly49h, the BXD-8 strain expresses the full C57BL/6
Ly49 repertoire, strongly supporting the specificity of the
antibody (15).
Interestingly, the RNA expression of Ly49h strongly
correlated with protein expression as determined by the
size of Ly49H  NK cell population and the level of its ex-
pression on single cell. The size of the Ly49H  NK cell
population varied in transgenic lines with 45 and 28% of
Ly49H  NK cells in lines Tg832 and Tg915, respectively
(P   0.005; Fig. 4 B). Moreover, the median of fluores-
cence intensity (MFI) of the Ly49H  NK cells was signifi-
cantly different with a MFI of 5.5   0.4 for line Tg832 and
MFI of 3.6   0.3 for line Tg915 (P   0.005). These differ-
ences correlated with RNA expression of Ly49h and may
depend on either the number of Ly49h copy or the site of
integration of the constructs. As expected, no significant
expression was observed in lines Tg985 and Tg043, which
lack Ly49h coding sequences.
Ly49H Confers Resistance to MCMV Infection. The phe-
notypic consequences of BAC128D23 expression in resis-
tance to infection with MCMV was evaluated in the prog-
eny of a cross between transgenic animals and the
susceptible mouse strain BXD-8. This strain expresses the
full  Ly49C57BL/6 repertoire with the exception of Ly49h
(15). As shown in Fig. 4 C, transgenic expression of the
212-kb BAC 128D23 clone conferred resistance to
MCMV infection in BXD-8 mice. Among the four BAC
128D23 lines included in our analysis, line Tg832 is of par-
ticular interest because it presented splenic viral titers com-
parable to those of resistant C57BL/6 mice (102 PFU/
spleen), whereas line Tg915 presented an intermediate
phenotype (103-104 PFU/spleen; Fig. 4 C). As expected,
lines Tg985 and Tg043 lacking Ly49h allowed uncon-
trolled viral replication at the same level as those of suscep-
tible strains (104–105 PFU/spleen).
To reduce the rescuing interval further, we used the
same functional assay to test a 79-kb XhoI and SalI frag-
Figure 2. Characterization of BAC clone 13J11 transgenic lines. (A)
Physical map of BAC clone 13J11 with the localization of markers used
for identification of transgenic lines by PCR. The black bar indicates the
physical domain common to two independent mapping efforts for Cmv1
(references 9 and 10). The ( ) indicates a positive result in STS content
analysis of transgenic founder animals. (B) RT-PCR for EST335500 and
Gapdh control RNA from spleens of wild-type strains and transgenic lines
mice. (C) Replication of MCMV in the spleen and liver of inbred and
transgenic lines. Viral titers in the organs of mice per group were deter-
mined by plaque assay 3 d after infection with 5   103 PFU of MCMV.T
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ment of BAC128D23 encompassing a single functional
gene, Ly49h. Out of two transgenic lines carrying the com-
plete construct (Fig. 5 A), only one line Tg814, was shown
to express Ly49H in  35% of DX5  NK cells (Fig. 5 B).
Phenotypic analysis of line Tg814 demonstrated that trans-
genic animals acquired MCMV resistance upon introduc-
tion of the 79-kb transgene (Fig. 5 C). It is important to
note, however, that at this early time point the effect of
Cmv1 (or the transgene) is observed primarily in the spleen
(see below; reference 4). The proper expression of Ly49H
in line Tg814 indicates that Cmv1 gene and its requisite
regulatory sequences are contained within the genomic
construct. These results showed that MCMV susceptibility
can be reversed by proper expression of a single functional
gene, Ly49h, thereby providing the formal demonstration
of allelism between Ly49h and Cmv1. In addition, partial
Table I. Summary of Genetic and Phenotypic Analysis of Transgenic Mice Expressing Ly49H
Transgenic line
Integration of
BAC DNA
Ly49h
copy no.
Ly49h RNA
expression
Protein expression
of Ly49Ha
MFI of
Ly49H  cellsb
Viral titer
on spleenc
212 kb full BAC 128D23
Tg832 Intact 3–4     45.3   3% 5.5   0.4 2.1   0.4
Tg915 Intact 1   28   2% 3.6   0.3 3.1   0.4
Tg985 Partial 0 No 6   1% N/D 4.8   0.3
Tg043 Partial 0 No 3   1% N/D 4.7   0.4
79 kb SalI-XhoI fragment of BAC 128D23
Tg796 Intact N/D No N/D N/D 4.5   0.2
Tg814 Intact N/D    35   2% 4.6   0.3 2.3   0.2
Data analyzed on four mice in each group on FVB/N background, except for Tg814, of which three mice were analyzed. Similar data were obtained
for transgenic mice in the context of the BXD-8 or BALB/c.
aIndicates the percentage of Ly49H  population among DX5  cells in the spleen (mean   SD).
bIndicates median of fluorescence intensity of Ly49H  cells (mean   SD).
cIndicates log10 PFU/organ (mean   SD). For controls, viral titers for resistant C57BL/6 and susceptible FVB/N were 2.0   0.3 and 4.5   0.2, re-
spectively.
Figure 3. Characterization of
BAC clone 128D23 transgenic lines.
(A) Physical map of BAC clone
128D23 with the localization of
markers used for identification of
transgenic lines by PCR. The local-
ization of genes present in the BAC
clone is also indicated. The ( ) indi-
cates a positive result in STS content
analysis of transgenic founder ani-
mals. Restriction sites of XhoI and
SalI were shown. (B) Semiquantita-
tive PCR to determine transgene
copy number on founders. Ly49h-
specific primers were used to amplify
1–7 copies of BAC DNA. Results
were compared with those obtained
from transgenic lines in 26 cycles of
amplification. (C) RT-PCR for
genes contained in BAC clone
128D23 and Gapdh control RNA
from spleens of wild-type mice and
transgenic lines. Ly49h, Ly49d, and
Ly49i oligonucleotide primer pairs
were designed to amplify specifically
the C57BL/6 alleles (see Materials
and Methods).T
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recovery observed in line Tg915 shows a gene dosage ef-
fect indicating a threshold value in providing resistance
above 28% of Ly49H  cells.
Ly49H Confers Resistance to MCMV Infection Independently
of the Genetic Background. With the exception of the 23-
kb deletion encompassing Ly49h, the susceptible BXD-8
and the resistant C57BL/6 strains are identical at the Cmv1
locus (15). In contrast, classical inbred strains present two
independent susceptible haplotypes. In particular, suscepti-
ble BALB/c and A/J (used for genetic mapping) and
FVB/N (used for transgenesis) present unrelated haplo-
types for all loci analyzed in the vicinity of Cmv1 (14).
These results indicated two independent origins for the
MCMV susceptibility Cmv1s allele and suggested the pos-
sibility of genetic heterogeneity at Cmv1, such as muta-
tions in alternate Ly49h members in different inbred
strains. In addition, a BALB/c modifier gene of MCMV
resistance has been proposed to be present in the distal
candidate region (9). Moreover the susceptibility to
MCMV has been shown to be controlled by various cyto-
kines and chemokines such as IFN- ,  , IL-12, TNF, and
macrophage inflammatory protein 1  (MIP-1 ; references
27–29) whose expression is very diverse in different ge-
netic backgrounds (30, 31). Thus, the rescue by the trans-
fer of Ly49h might be influenced by the variable level of
expression of these molecules.
To evaluate a possible effect of the genetic background
in MCMV susceptibility, the response of transgenic mice to
MCMV infection was investigated in the context of a ho-
mozygous Cmv1sBALB and Cmv1sFVB background. Five ani-
mals from lines Tg832 and Tg915 were analyzed as de-
scribed above. As shown in Fig. 6, A and B, both lines
supported similar levels of MCMV replication to those ob-
tained in the BXD-8 background, supporting a critical role
Figure 5. A 79-kb genomic construct containing Ly49H confers resistance
to MCMV infection. (A) Physical map of a 79-kb fragment with the localiza-
tion of markers used for identification of transgenic lines by PCR. The local-
ization of genes present in the BAC clone is also indicated. Restriction sites
of XhoI and SalI used to generate the 79-kb fragment were shown. The ( )
indicates a positive result in STS content analysis of transgenic founder ani-
mals. (B) Enriched NK cell preparations from spleens of lines Tg832 and
Tg814 were stained with the mAb DX5 and the rabbit polyclonal antibody
against the cytoplasmic domain of the Ly49H. The numbers in the density
plots indicate the percentage of DX5  lymphocytes either Ly49H  or
Ly49H . (C) Replication of MCMV in the spleen and liver of wild-type and
transgenic lines. Viral titers in the spleen of five mice per group were deter-
mined by plaque assay 3 d after infection with 5   103 PFU of MCMV.
Figure 4. Acquisition of MCMV-resistance in BAC clone 128D23 transgenic lines. (A) Enriched NK cell preparations from spleens of wild-type strains
were stained with the mAb DX5 and the rabbit polyclonal antibody against the cytoplasmic domain of the Ly49H peptide reported here. The numbers in
the density plots indicate the percentage of DX5  lymphocytes either Ly49H  or Ly49H . (B) Enriched NK cell preparations from spleens of BAC
128D23 transgenic lines were stained with the monoclonal antibody DX5 and the rabbit polyclonal antibody against the cytoplasmic domain of the
Ly49H. The numbers in the density plots indicate the percentage of DX5  lymphocytes either Ly49H  or Ly49H . (C) Replication of MCMV in the
spleen of wild-type and transgenic lines. Viral titers in the spleen of five mice per group were determined by plaque assay 3 d after infection with 5   103
PFU of MCMV. Statistically significant differences were observed between transgenic (Tg832, Tg915) and nontransgenic mice at P values of   0.0005.T
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for Ly49H in MCMV resistance independent of the ge-
netic background.
Regulation of Trans-Ly49H Expression in Transgenic Mice.
The identification of Ly49H as the critical resistance factor
in host response to MCMV predicted that cells expressing
Ly49H should display evidence of specific activation during
MCMV infection in vivo. Soon after MCMV infection,
there is a general activation of NK cells to produce IFN- 
and proliferate in the spleen (32). At later time points, there
is a specific expansion of Ly49H  cells in C57BL/6 mice
(32), while expression of MIP-1  promotes recruitment of
NK cells and formation of inflammatory foci in the in-
fected liver (29).
To investigate whether control sequences for clonal ex-
pansion are present in the transgenic construct, we fol-
lowed Ly49H expression by FACS® analysis of DX5  NK
cells isolated from spleen and liver over a 1-wk period after
infection. The kinetics of the Ly49H  NK cell expansion
was identical for wild-type C57BL/6 mice and the line
Tg832 (Fig. 7 A). The percentage of splenic and liver NK
cells expressing Ly49H gradually increased during infection
(Fig. 7 A). By day 7, the proportion of NK cells in spleen
and liver expressing Ly49H was  70%, compared with
only 50% in spleens of mock-infected mice. Importantly,
the increased percentage of Ly49H  cells in the liver was
accompanied by an enhanced control of viral titers in these
organs, supporting a direct role for this receptor in MCMV
resistance in the liver (Fig. 7 B). Taken together, these re-
sults indicate a proliferation of Ly49H  NK cells during in-
fection and demonstrate that regulation of the Ly49h trans-
gene is indistinguishable from that of its endogenous
counterpart in C57BL/6 mice, possibly due to specific acti-
vation through the Ly49H receptor itself.
Discussion
Ly49h was identified as a strong candidate for Cmv1
based on the following observations: (a) it mapped within
the minimal genetic and physical intervals delineating the
Cmv1 region (11); (b) a 23-kb deletion encompassing
Ly49h in the context of a C57BL/6 (Cmv1r) is associated
with susceptibility (15); (c) expression of Ly49h is re-
stricted to Cmv1r mice (15, 16); (d) Ly49h encodes for a
C-type lectin activating receptor specifically expressed on
NK cells (19); (e) depletion of Ly49H  NK cell popu-
lations abrogates MCMV-resistance (16, 17); (f) Ly49H
recognizes an MCMV-encoded molecule, m157, a GPI-
membrane bound protein that is expressed early during in-
fection (21, 22).
While these data provide compelling evidence of the
role of Ly49h in MCMV infection, important questions re-
main to be clarified concerning the association between
Ly49h and Cmv1: (a) an independent genetic mapping ef-
fort identified a region distal to the Ly49 cluster as associ-
ated with the MCMV-susceptibility phenotype (9), this re-
gion, referred to as the distal candidate region, was also
detected by haplotype analysis in genealogically and phylo-
genetically unrelated inbred strains of mice (14); (b) the
minimal  Cmv1 physical interval was shown to contain
other genes that were potential candidates for an infection
resistance locus. For example Csda, that encodes a putative
repressor for human GM-CSF, a key molecule for mac-
rophage maturation (33), or the spleen-specific gene,
EST335500, described here, are both localized in the vi-
cinity of the distal candidate region; (c) functional analysis
with monoclonal antibodies could be misleading because
the possibility of cross-reactivity with a yet to be identified
Figure 6. Ly49H confers resistance to MCMV infection independently of the genetic background. Replication of MCMV in wild-type and transgenic
Tg832 and Tg915 mice in the context of homozygous FVB/N (Cmv1sFVB; A) and BALB/c (Cmv1sBALB; B) was shown. Haplotypes of Ly49 family for Cmv1r
(C57BL/6), Cmv1sFVB and Cmv1sBALB are shown; black boxes, B6 alleles; hatched boxes, FVB alleles; gray boxes, BALB/c alleles; white boxes indicate the
absence of alleles. Viral titers in the spleen and liver of five mice per group were determined by plaque assay 3 d after infection with 5   103 PFU of MCMV.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
523 Lee et al.
member of the Ly49 family; (d) the presence of two
independent origins for the Cmv1s alleles, Cmv1sFVB or
Cmv1sBALB, suggested that MCMV susceptibility could be
associated with either independent mutations on the same
gene or mutations in tightly linked genes within the Cmv1
interval (14).
To address these questions, we performed experiments
in which we transferred cloned copies of two important re-
gions within the minimal Cmv1 interval onto a susceptible
(Cmv1sFVB or Cmv1sBALB) genetic background and analyzed
the effects of this transfer on resistance to infection. In the
present study, we have shown that transfer of DNA con-
structs that overlap the distal candidate region did not affect
resistance, whereas transfer of genomic constructs overlap-
ping Ly49h caused gain-of-function on an otherwise sus-
ceptible background. Moreover, using a 79-kb genomic
fragment containing no functional gene other than Ly49h,
the phenotypic rescue obtained in these experiments was
complete, unambiguous, and quantitative. Combined with
the previous positional cloning studies and the antibody de-
pletion experiments, the transgenic transfer of Ly49h pre-
sented here unequivocally establishes that Ly49h and Cmv1
are allelic.
Our results did not detect either a gain-of-function after
genetic transfer of the distal construct BAC 13J11 or a loss-
of-function in Ly49h-transgenic animals in the BALB/c
context. A possible effect of genes distal to the Ly49 cluster
was previously suggested by genetic analysis using crosses
between the MCMV-resistant C57BL/6 and the MCMV-
susceptible BALB/c or A/J mouse strains (9). The gene
EST335500 presented here was of particular interest be-
cause it is flanked by markers defining the distal region in-
volved in MCMV resistance and it is specifically expressed
in the spleen, which is a main site of control of MCVM
replication. Moreover, EST335500 transcript is present in
tissues of Cmv1r C57BL/6 mice, while it is absent in those
of Cmv1s BALB/c or A/J mice, indicating a possible role in
MCMV resistance. However, lack of complementation
with 13J11 transgenic mice indicates that polymorphisms
in this genomic domain, including those identified in
EST335500, do not affect the MCMV response, as mea-
sured by splenic or liver viral titers. However, we cannot
rule-out at this time the possibility of a MCMV strain–spe-
cific effect as we have used the original Smith strain (34),
while others have used the strain K181 (9, 12, 35). K181 is
considered to be a more virulent strain, as at a similar infec-
tious dose it produces more plaques and cytopathic effects
than the Smith strain, which might allow the detection of
more subtle effects of genomic regions distinct from Ly49h
in antiviral response (36). The transgenic models reported
here will allow us to test this possibility.
The use of genomic DNA in transgenesis has the advan-
tage of allowing the function and regulation of genes to be
studied in conditions approaching their natural context. In-
deed, this is the first study reporting successful production
of mice that are transgenic for an activating NK receptor
Figure 7. Kinetics of trans-Ly49H expression. (A) Ly49H expression was followed during a 1-wk period in the transgenic line Tg832 and C57BL/6 by stain-
ing with the mAb DX5 and a rabbit polyclonal antibody against the cytoplasmic domain of the Ly49H. The numbers in the density plots indicate the percent-
age of DX5  lymphocytes either Ly49H  or Ly49H . Enriched NK cell preparations were obtained from spleen and liver tissues after 0, 1, 2, 3, 5, and 7 d after
infection. The proportion of NK cells in liver until 3 d after infection was not determined owing to the insignificant number of DX5  cells on samples. (B) A
fraction of the organ homogenates used in panel A were used to determine the course of MCMV infection at the indicated time points in transgenic Tg832
mice and wild-type C57BL/6 (Cmv1r) and FVB/N (Cmv1s) controls. Viral titers were determined by plaque after infection with 5   103 PFU of MCMV.T
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whereas several transgenic mice expressing inhibitory
Ly49s were previously generated (37–40). Ly49 gene ex-
pression is known to be regulated in an isoform-specific
fashion, by a process that restricts the number of Ly49
genes expressed per single NK cell and generates clonal
variability (19, 41, 42). Furthermore, Ly49H protein is ex-
pressed on the surface of 56% of NK1.1 CD3  splenic NK
cells (19), the cell population known to be engaged by
Cmv1. Using a polyclonal antibody specific for the cyto-
plasmic tail of Ly49H we observed the appearance of the
Ly49H protein in transgenic NK cells and restoration of re-
sistance to infection, suggesting that the regulatory se-
quences for proper expression of the gene are contained
within the genomic fragment used for transgenesis. More-
over, trans-Ly49H expression seems to be NK cell specific
since no expression was observed in other lymphocyte lin-
eages, such as T or B cells in flow cytometric analysis of
total splenocytes. So far, little is known about cis- and trans-
elements that regulate activating Ly49 receptors. A com-
parative analysis of the promoter regions of mouse Ly49
genes indicated the presence of two consensus binding sites
for the T cell factor 1 (TCF-1), a member of the high mo-
bility group protein family (43), immediately upstream of a
predicted TATA box (44). Using TCF-1 /  mice, Held
and coworkers demonstrated that TCF-1 was essential for
acquisition but not maintenance of expression of Ly49 re-
ceptors, such as Ly49A and Ly49D, as the size of the
Ly49A and D populations were greatly reduced in the
knockout mice in contrast to the level of receptor expres-
sion in individual cells (45). Our results indicate that se-
quences within the 79-kb genomic construct are sufficient
to direct proper acquisition and maintenance of Ly49H ex-
pression by a mechanism distinct to that involving TCF-1.
This mechanism, however, would also act at the transcrip-
tional level, as Ly49H protein levels, determined by both
the size of Ly49H  population and MFI per individual cell,
parallels Ly49h RNA expression levels in the various trans-
genic lines produced here.
Our observation that the transgenic line Tg915 pre-
sented a Ly49H  cell population of reduced size and
splenic viral titers intermediate to those present in Cmv1r
or Cmv1s mouse strains revealed a previously unforeseen
gene dosage effect for Ly49H function and defined a
threshold level of Ly49H  NK cells (28%) necessary for
full resistance to MCMV infection. This result indicates
that line Tg915 carries a hypomorphic Cmv1 allele, which
is an allele with reduced expression compared with Cmv1r.
This leads one to predict that transgenic overexpression of
Cmv1/Ly49h in more than 50% of NK cells should have
the hypermorphic effect of increased resistance - that is
lower splenic viral titers and shorter span of the acute in-
fectious phase - in comparison with C57BL/6. However,
we have not observed higher levels of Ly49h transcript in
any of the transgenic animals obtained, suggesting that up-
per levels of transcript and/or protein expression are tightly
regulated. This might reflect the fact that expression of
Ly49 genes is developmentally controlled (42). It is
thought that NK cells acquire Ly49 receptors until they
generate sufficient inhibitory signals to balance their acti-
vation signals (42, 46). Thus, overexpression of activating
receptors could be deleterious for mouse development by
preventing a process that is crucial to ensure the induction
of NK cell self-tolerance.
Complementation was observed in two independent ge-
netic backgrounds carrying either the susceptibility allele
Cmv1sBALB or Cvm1sFVB. We have shown that a group of
susceptible strains including FVB/N and 129 carry a similar
haplotype at Cmv1 that is related to that of C57BL/6, in
opposition to susceptible strains such as BALB/c that do
not share alleles at any of the 13 loci studied (14). This is
particularly noteworthy at the level of the sequence and
functional diversity for genes of the Ly49 family. The role
of inhibitory NK cell receptors in the response to MCMV
is underscored by the recent characterization of MCMV
mechanisms to escape NK cell recognition. MCMV is able
to subvert the NK cell recognition system by deploying
MHC class I homologues that confer resistance to both the
innate and adaptive immune systems. Interestingly, those
mechanisms may differ in different inbred strains of mice.
The first of these viral encoded class I homologues to be
identified (m144) was found to confer resistance to NK cell
mediated attack in BALB/c mice (47) and is thus likely to
represent a ligand for an inhibitory NK receptor in this
strain. In a recent report, Arase et al. established that
Ly49H was being activated by a second viral-encoded class
I homologue known as m157 (21). Interestingly, m157 also
engages the inhibitory receptor Ly49I from 129 mice but it
does not bind to NK cells from BALB/c mice (21). While
the presence of Ly49I in FVB/N mice remains to be con-
firmed, initial cloning experiments (data not shown) and
haplotype analysis (14) indicate that FVB/N and 129 share
a similar Ly49 repertoire. Thus, results presented here indi-
cate that engagement of Ly49H is sufficient to override in-
hibitory signals prompted by either m144 or m157.
Selective recognition of the pathogen is a key step for an
effective innate immune response. The major targets of in-
nate immune recognition are pathogen-associated molecu-
lar patterns (PAMPs; reference 48). PAMPs represent con-
served molecular structures produced only by microbes
and essential for their survival. Peptidoglycan and li-
popolysaccharide are good examples of bacterial PAMPs.
Although recognition of viral double-stranded RNA is an
example of PAMP recognition, viruses pose a particular
problem for specific recognition, as all the components of
the virus are synthesized and assembled in the host cell. So
far, two alternative strategies were shown to be used by
NK cells to detect unhealthy cells: recognition of the ab-
sence of self in the case of MHC class I recognition by NK
cell inhibitory receptors (49) and recognition of altered
self, in the case of stress molecule recognition (ULBPs,
H-60, RAE-1; reference 50). The demonstration that spe-
cific resistance to MCMV is attributed to Ly49H protein
expression independently of other MCMV-mediated ef-
fects clearly demonstrates that NK cells are also able to me-
diate specific recognition and destruction of infected cells
through individual surface receptors. Important next ques-T
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tions are whether Ly49H is a component of the innate im-
mune system that is ‘hard-wired’ to detect MCMV (21,
22) or whether it is less restricted in that it recognizes other
yet to be identified ligands. In addition to the Cmv1 gene,
the murine NKC region has been linked to loci contribut-
ing to susceptibility to cutaneous leishmaniasis (51), ec-
tromelia virus (52), and herpes simplex I virus (53). These
susceptibility traits all involve NK cell–mediated immu-
nity, and the C57BL/6 mouse presents the active, “resis-
tant” allele. Transgenic mice reported here will be instru-
mental to test the proposal that such functions are strictly
dependent on activating members of the Ly49 family and
will support a direct role of these molecules in recognition
of foreign antigens.
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